Trials / Completed
CompletedNCT01212471
A Dose Ranging Study to Evaluate Safety and Efficacy of Bromfenac Ophthalmic Solution in Dry Eye Disease
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 840 (actual)
- Sponsor
- Bausch & Lomb Incorporated · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A dose ranging study to evaluate safety and efficacy of bromfenac ophthalmic solution in dry eye disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bromfenac Ophthalmic Solution A | sterile ophthalmic solution |
| DRUG | Bromfenac Ophthalmic Solution B | sterile ophthalmic solution |
| DRUG | Placebo Comparator | sterile ophthalmic solution |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2011-08-01
- Completion
- 2011-12-01
- First posted
- 2010-09-30
- Last updated
- 2020-09-04
- Results posted
- 2020-09-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01212471. Inclusion in this directory is not an endorsement.